RxDoctor Payments Data

Tricia Vandehey, MD

Family Medicine · Defiance, OHNPI 1053302471

Payments from drug & device makers

$910in general payments, 2019–2025

Across 58 payments — averaging $15.69 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$236
  • Pfizer$221
  • Novartis$85
  • Abbott$53
  • Dexcom, Inc.$38
  • AstraZeneca$37
  • plus $240 from 12 others

What the payments were for

  • Food & beverage$89098%
  • Other$202%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$910 in reported general payments places this provider in the 60th percentile of 3,983 family medicine providers in Ohio.

See all family medicine providers in Ohio

Medicare billing

Part B allowed, 2024
$99,654
Medicare patients
360
Services billed
1,509

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MounjaroTirzepatide76$111,503
EliquisApixaban80$77,959
OzempicSemaglutide59$73,106
JardianceEmpagliflozin42$69,540
Trelegy ElliptaFluticasone/Umeclidin/Vilanter44$38,768
LinzessLinaclotide35$35,032
XareltoRivaroxaban21$32,354
RybelsusSemaglutide12$25,623
JanuviaSitagliptin Phosphate16$25,488
TrulicityDulaglutide14$16,780
Lantus SolostarInsulin Glargine,hum.Rec.Anlog34$13,907
Breo ElliptaFluticasone/Vilanterol15$6,697
Advair HfaFluticasone Propion/Salmeterol16$5,703
Levothyroxine Sodium502$5,564
Budesonide-Formoterol FumarateBudesonide/Formoterol Fumarate11$4,984

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro, Trulicity$23$128,28390 claims
Novo NordiskOzempic, Rybelsus$15$98,72971 claims
PfizerEliquis, Paxlovid$221$82,31894 claims
GSKTrelegy Ellipta, Breo Ellipta$32$45,46559 claims
AbbVieLinzess$236$35,03235 claims
Johnson & JohnsonXarelto$25$32,35421 claims
MerckJanuvia$21$25,48816 claims
AstraZenecaSymbicort$37$4,92820 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 3,983 family medicine providers in Ohio.

Other family medicine in Defiance

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →